相关实验视频
Updated: Jul 12, 2025

07:25
Transdermal Measurement of Glomerular Filtration Rate in Mice
Published on: October 21, 2018
22.0K
在患有严重功能障碍的患者中,多提努拉德的疗效
Osamu Kurihara1, Takehisa Yamada2, Katsuhito Kato3
1Cardiovascular Center, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamakari, Inzai, Chiba, 270-1694, Japan. kurihara-1980@nms.ac.jp.
Clinical and experimental nephrology
|October 21, 2023
概括
在慢性病 (CKD) 患者中,多提努拉德有效降低了血清尿酸 (UA). 这种药物显著改善了严重功能障碍患者的功能 (eGFR < 30 mL/min/1.73 m2).
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 超尿血与慢性病 (CKD) 的进展有关,但尿酸 (UA) 降低疗法的疗效仍在争论中.
- 多提努拉德是一种新型尿素酸药物,可以选择性地抑制UA的再吸收.
- 它对严重功能障碍的功能的影响尚未得到充分证实.
研究的目的:
- 评估多提努拉德对严重功能障碍患者血清UA水平和功能的影响.
- 评估药物在功能障碍不同阶段的疗效.
主要方法:
- 对53名患有高尿血症的门诊患者进行了回顾性分析,这些患者接受了dotinurad治疗.
- 根据基线估计的淋巴细胞过率 (eGFR) 将患者分为三组:<30,30-44,≥45毫升/分钟/1.73米2.
- 随访期平均为9.8个月.
主要成果:
- 在所有患者群体中,血清UA水平显著下降.
- 在基线EGFR<30mL/min/1.73m2 (P=0.032) 的患者中,功能 (eGFR) 显著改善.
- 较高比例的EGFR<30mL/min/1.73m2的患者表现出改善的EGFR (P=0.038);基线EGFR<30并实现UA ≤6.0 mg/dL预测的改善.
结论:
- 多提努拉德在CKD患者中表现出UA降低作用.
- 该药物显示出改善功能的潜力,特别是在严重功能障碍患者中.
- 进一步的研究可能会阐明dotinurad在控制CKD进展中的作用.
相关概念视频
Renal Failure: Dose Adjustments
97
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
97
Acute Kidney Injury IV: Diagnostic Studies and Prevention
19
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
19
Renal Drug Excretion: Tubular Secretion
196
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
196
Factors Affecting Renal Clearance: Renal Impairment
101
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
101
Renal Drug Excretion: Tubular Reabsorption
193
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
193
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
140
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
140

